IGF-1 LR3

Resumen del Protocolo

Resumen conciso del once-daily subcutaneous regimen.

• Objetivo:Support anabolic processes and metabolic function through enhanced IGF-1 activity with extended bioavailability.
• Programa:Inyecciones subcutáneas diarias por 8 semanas (standard cycle); may extend to 12 semanas with appropriate off-periods.
• Rango de dosis:20–50 mcg daily with gradual titration; conservative protocols remain at ≤50 mcg/day.
• Reconstitución:3.0 mL por vial de 1 mg (~0.333 mg/mL or 333 mcg/mL) for precise unit measurements.
• Almacenamiento:Lyophilized powder frozen at −20 °C (−4 °F); reconstituted solution refrigerated at 2–8 °C (35.6–46.4 °F); evitar congelar y descongelar repetidamente.
• Cycling:Common approach is 8 semanas on, 4–8 semanas off to prevent receptor desensitization.

Protocolo de Dosis

Enfoque de dosis diaria sugerido for tolerance assessment.

• Start (Semanas 1–2):20 mcg daily para evaluar tolerancia, particularly regarding blood glucose effects.
• Titrate (Semanas 3–4):Aumentar to 40 mcg daily if Semana 1–2 well-tolerated with no significant hypoglycemic symptoms.
• Maintain (Semanas 5–8):Hold at 50 mcg daily; this is considered the conservative upper end for most research protocols.
• Frecuencia:Una vez al día subcutáneamente; timing often aligned with meals (morning or post-workout) to manage insulin-like effects.
• Duración del ciclo:8 semanas is standard; 12-semana protocols exist but may show diminished returns beyond Semana 6–8.
• Site Rotation:Rotar sitio de inyeccións systematically (abdomen, thighs, upper arms) to prevent local irritación or lipohypertrophy.

Pasos para Reconstituir

• Extraer3.0 mLde agua bacteriostática con una jeringa estéril.
• Inyectar slowly down the vial wall to avoid foaming; do not shake.
• Gently swirl or roll until the lyophilized powder dissolves completely into a clear solution.
• Label the vial with reconstitution date and refrigerate at2–8 °C (35.6–46.4 °F), protegido de la luz.
• Utilizar en un plazo de30 díasde la reconstitución; for longer storage, prepare aliquots and freeze at −20 °C (−4 °F) por hasta 3–6 months.

Posibles Beneficios

Observations de la literatura preclínica y clínica on IGF-1 and its analogs.